Autolus Therapeutics presents AUTO1 and AUTO3 data at the 2020 EHA25 Virtual Congress
Pivotal AUTO1 study in adult ALL patients enrolling– AUTO1 continued favorable safety profile and high level of clinical activity, pivotal […]
Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise
Spleen response rates in first-line patients at 12 weeks and 24 weeks in line with previously reported data and differentiated […]
Agios Announces Clinical Proof-of-Concept Has Been Established in Phase 1 Study of Mitapivat, First-in Class PKR Activator, in Sickle Cell Disease
– 5 of 8 (63%) Efficacy Evaluable Patients Achieved a Hemoglobin Increase of ≥1.0 g/dL From Baseline –– Safety Profile […]
Kaixin Auto Holdings Announces Entry into a Subscription Agreement
BEIJING, June 12, 2020 (GLOBE NEWSWIRE) — Kaixin Auto Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN), one of the primary […]
Galantas Reports Results for the Year Ended December 31, 2019
TORONTO, June 12, 2020 (GLOBE NEWSWIRE) — Galantas Gold Corporation (the ‘Company’) (TSXV & AIM : Symbol GAL) is pleased […]
High Standard Health Care Limited Receives Purchase Order For Medical Gowns
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, June 12, 2020 […]
NXP Selects TSMC 5nm Process for Next Generation High Performance Automotive Platform
Collaboration combines NXP’s automotive quality and functional safety with TSMC’s industry-leading 5nm technology to further drive the transformation of automobiles […]
WISeKey renews strategic IoT patent for the digital authentication method of valuable goods on the Internet
Zug, Switzerland, June 12, 2020 – WISeKey International Holding Ltd (“WISeKey” or “Company”) (SIX: WIHN, NASDAQ: WKEY), a leading global […]
TSX News -
The Keg Royalties Income Fund Announces June 2020 Cash Distribution
VANCOUVER, British Columbia, June 11, 2020 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) today announced […]
Generation Bio Announces Pricing of Initial Public Offering
CAMBRIDGE, Mass., June 11, 2020 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a […]
